| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |